Want to see CLOV full AI Analyst Report?
CLOV Stock Chart & Stats
$2.19
-$0.09(-2.50%)
At close: 4:00 PM EST
$2.19
-$0.09(-2.50%)
Day’s Range― - ―
52-Week Range$1.58 - $5.59
Previous CloseN/A
Volume2.53M
Average Volume (3M)8.20M
Market Cap
$2.34B
Enterprise Value$2.31B
Total Cash (Recent Filing)$177.56M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.57
Next Earnings
Aug 05, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding430,969,400
10 Day Avg. Volume5,895,495
30 Day Avg. Volume8,198,115
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)3.94
Price to Sales (P/S)0.63
P/FCF Ratio-17.62
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue1.05
Enterprise Value/Gross Profit5.69
Enterprise Value/Ebitda-41.92
Forecast
1Y Price Target
$4.48Price Target Upside104.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.04
Revenue Forecast (FY)$2.91B
Bulls Say, Bears Say
Bulls Say
Membership Growth & Market DensityRapid, sustained enrollment (~51% YoY to ~156k) and concentrated market density (largest PPO in New Jersey) create durable unit‑economy advantages. Scale strengthens provider leverage, retention, and cohort maturation, enabling lasting medical‑cost improvements and more predictable margins.
Conservative Balance Sheet & Improving Cash FlowA virtually debt‑free balance sheet with meaningful cash ($418M) and positive trailing‑twelve‑month operating and free cash flow provides durable financial flexibility. This reduces refinancing risk, funds self‑investment, and cushions execution as cohorts mature and margins normalize.
Higher CMS Star Ratings (structural Tailwind)Court‑driven CMS recalculation raising key contracts to 4.5 Stars materially improves eligibility for quality‑linked payments and member appeal. Higher ratings are a structural advantage that can increase bonus revenue, support enrollment growth, and enhance competitive position over multiple Medicare cycles.
Bears Say
Profitability Remains InconsistentAlthough Q1 showed GAAP net income, the TTM net margin remains negative (~‑2.6%) and historical profits have been uneven. Durable shareholder returns and reinvestment capacity hinge on sustained cohort economics; persistent volatility would constrain capital allocation and margin durability.
Elevated Outpatient Utilization PressurePersistently elevated outpatient utilization is a structural cost driver that can keep medical loss ratios high as membership scales. Controlling outpatient trends requires sustained provider engagement and clinical programs; failure to do so would materially compress long‑term margins.
Part D And Risk‑adjustment UncertaintyOngoing uncertainty around Part D dynamics and risk‑adjustment normalization creates structural revenue variability. Changes to CMS models, encounter timing, or reserve development can materially swing premium revenue and margins, reducing predictability of government‑funded cash flows.
Clover Health Investments News
CLOV FAQ
What was Clover Health Investments Corp’s price range in the past 12 months?
Clover Health Investments Corp lowest stock price was $1.58 and its highest was $5.59 in the past 12 months.
What is Clover Health Investments Corp’s market cap?
Clover Health Investments Corp’s market cap is $2.34B.
When is Clover Health Investments Corp’s upcoming earnings report date?
Clover Health Investments Corp’s upcoming earnings report date is Aug 05, 2026 which is in 22 days.
How were Clover Health Investments Corp’s earnings last quarter?
Clover Health Investments Corp released its earnings results on May 06, 2026. The company reported $0.073 earnings per share for the quarter, beating the consensus estimate of $0.069 by $0.004.
Is Clover Health Investments Corp overvalued?
According to Wall Street analysts Clover Health Investments Corp’s price is currently Undervalued.
Does Clover Health Investments Corp pay dividends?
Clover Health Investments Corp pays a N/A dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Clover Health Investments Corp dividends here
What is Clover Health Investments Corp’s EPS estimate?
Clover Health Investments Corp’s EPS estimate is 0.04.
How many shares outstanding does Clover Health Investments Corp have?
Clover Health Investments Corp has 430,969,400 shares outstanding.
What happened to Clover Health Investments Corp’s price movement after its last earnings report?
Clover Health Investments Corp reported an EPS of $0.073 in its last earnings report, beating expectations of $0.069. Following the earnings report the stock price went up 5.224%.
Which hedge fund is a major shareholder of Clover Health Investments Corp?
Currently, no hedge funds are holding shares in CLOV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clover Health Investments Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.48 (104.34% Upside)
$4.48 (104.34% Upside)
Blogger Sentiment
Bullish
CLOV Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $574.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 2.7%
Last 30 Days ▲ 4.1%
Last 30 Days ▲ 4.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
45.57%
12-Months-Change
Fundamentals
Return on Equity
-17.08%
Trailing 12-Months
Asset Growth
19.53%
Trailing 12-Months
Company Description
Clover Health Investments Corp
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
CLOV Stock 12 Month Forecast
Average Price Target
$4.48
▲(104.34% Upside)
Technical Analysis
Ownership Overview
6.96% Insiders
7.90% Mutual Funds
0.03% Other Institutional Investors
73.83% Public Companies and
Individual Investors